Toso Activators could potentially refer to a group of compounds or molecules that exhibit the ability to induce or enhance the activity of the Toso protein, also known as FAIM3. Toso, or FAIM3, is recognized for its involvement in the regulation of apoptosis, serving as a receptor for immunoglobulin M (IgM) in certain contexts. Toso Activators may comprise a diverse range of chemical entities with the capacity to modulate the signaling pathways associated with Toso, ultimately leading to an increase in its activation or function.
These activators could function through various mechanisms, including direct interaction with Toso, modulation of upstream signaling pathways, or influencing the expression levels of Toso itself. For instance, small molecules that enhance the binding affinity between Toso and IgM could be considered Toso Activators. Alternatively, compounds that stimulate the expression of Toso at the transcriptional or post-transcriptional levels may also fall into this category. The development and characterization of Toso Activators would likely involve rigorous biochemical and cellular assays to assess their specificity, potency, and downstream effects on Toso-mediated cellular processes, providing valuable insights into the regulation of apoptosis and immune responses.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor that activates TOSO through modulation of kinase activities. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Topoisomerase II inhibitor, activating TOSO by inducing DNA damage. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Chemotherapeutic inducing apoptosis by causing DNA damage, potentially activating TOSO. | ||||||
ABT 737 | 852808-04-9 | sc-207242 | 2.5 mg | $204.00 | 54 | |
BH3 mimetic activating apoptotic pathways linked to TOSO. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor activating cellular processes connected to TOSO. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Antitumor antibiotic inducing DNA crosslinking and apoptosis, potentially activating TOSO. | ||||||
PAC 1 | 315183-21-2 | sc-203174 sc-203174A | 10 mg 50 mg | $132.00 $536.00 | 1 | |
Caspase-3 activator directly impacting apoptotic pathways associated with TOSO activation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor inducing apoptosis in cancer cells, potentially activating cellular processes linked to TOSO. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Induces oxidative stress and apoptosis, potentially activating cellular mechanisms associated with TOSO. | ||||||